1. Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
    Myriem Boufraqech et al, 2019, Cancers CrossRef
  2. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer
    Aistė Kondrotienė et al, 2020, International Journal of Molecular Sciences CrossRef

  3. LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP


    Zixuan Gong et al, 2020, Cancer Management and Research CrossRef
  4. Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
    Lina Liu et al, 2022, Frontiers in Endocrinology CrossRef
  5. Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features
    Aistė Kondrotienė et al, 2021, Diagnostics CrossRef
  6. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
    Maria Papaioannou et al, 2022, Frontiers in Oncology CrossRef